PTC Therapeutics
PTCT
PTCT
206 hedge funds and large institutions have $2.94B invested in PTC Therapeutics in 2019 Q4 according to their latest regulatory filings, with 57 funds opening new positions, 67 increasing their positions, 60 reducing their positions, and 33 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
12% more funds holding
Funds holding: 184 → 206 (+22)
12% more repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 60
1.42% less ownership
Funds ownership: 100.6% → 99.18% (-1.4%)
Holders
206
Holding in Top 10
8
Calls
$53.6M
Puts
$44.4M
Top Buyers
| 1 | +$41.3M | |
| 2 | +$30.1M | |
| 3 | +$29.9M | |
| 4 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
+$20.8M |
| 5 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$19.5M |
Top Sellers
| 1 | -$55.9M | |
| 2 | -$54.9M | |
| 3 | -$37.1M | |
| 4 |
BC
Boxer Capital
San Diego,
California
|
-$33.8M |
| 5 |
SCM
Scopia Capital Management
New York
|
-$29.5M |